[1]
“THALIDOMIDE FOR PATIENTS WITH THALASSEMIA INTERMEDIA: A RETROSPECTIVE MULTICENTER CLINICAL STUDY”, Mediterr J Hematol Infect Dis, vol. 12, no. 1, p. e2020021, Apr. 2020, doi: 10.4084/mjhid.2020.021.